☆ 4.6 Article

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma

BMC CANCER (2022)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice

Ivana Peran et al.

Summary: The study showed that CDH11, expressed by cancer-associated fibroblasts in the pancreatic tumor stroma, plays a critical role in promoting tumor growth and immunosuppression. Knockout or inhibition of CDH11 reduced pancreatic tumor growth, increased response to gemcitabine, and significantly extended survival of mice. Thus, CDH11 may be a potential therapeutic target for pancreatic cancer.

GASTROENTEROLOGY (2021)

Add to Collection

Article Pathology

Diagnostic value of syndecan-4 protein expression in colorectal cancer

Doerthe Jechorek et al.

Summary: SDC4 plays a crucial role in the progression of colorectal cancer, with high expression associated with aggressive pathological features and reduced survival rates. Research on its impact on patient prognosis may offer clinical utility, identifying potential therapeutic targets in the diagnosis and treatment of CRC.

PATHOLOGY RESEARCH AND PRACTICE (2021)

Add to Collection

Article Cell Biology

Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma

Heng Yang et al.

Summary: SDC4 functions as a key therapeutic target in HCC, and small-molecule bufalin can inhibit HCC proliferation and migration by regulating the SDC4/DDX23 signaling axis.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer

Nilton Jose Santos et al.

Summary: Prostate cancer, a leading cause of cancer-related death in men, requires new biomarkers. Research on the expression pattern of proteoglycans and syntenin-1 in mouse models and human prostate tumors revealed SDC1, SDC3, SDC2, and SDC4 differences associated with cancer development, with SDC3 expression linked to shorter prostate-specific survival.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Serum syndecan-4 is associated with nonalcoholic fatty liver disease

Shu Jing Xia et al.

Summary: Elevated serum SDC4 levels are associated with metabolic disorders and the prevalence of NAFLD in the general population. Serum SDC4 may serve as a biomarker for NAFLD.

JOURNAL OF DIGESTIVE DISEASES (2021)

Add to Collection

Review Oncology

Syndecan-4 in Tumor Cell Motility

Aniko Keller-Pinter et al.

Summary: Cell migration is essential for the formation of metastasis and is a key feature of malignancy. Syndecan-4 (SDC4) plays a crucial role in cell migration by regulating various signaling pathways and biological processes. Its involvement in tumor progression has been demonstrated, highlighting its significance in cell movement and metastasis.

CANCERS (2021)

Add to Collection

Article Medicine, Research & Experimental

The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer

Huizhen Nie et al.

Summary: This study reveals that PRLR-SF is highly expressed in PDAC tissues and can inhibit the proliferation of PDAC cells by activating the Hippo signaling pathway, thereby slowing tumor growth. PRLR-SF affects metabolic reprogramming and PDAC progression by reducing the expression of genes involved in the Pentose Phosphate Pathway (PPP) and nucleotide biosynthesis.

THERANOSTICS (2021)

Add to Collection

Review Oncology

From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

Christopher Nevala-Plagemann et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection

Review Oncology

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Yunzhen Qian et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Syndecan-4 as a Marker of Endothelial Dysfunction in Patients with Resistant Hypertension

Mark Lipphardt et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Sulfated Glycoaminoglycans and Proteoglycan Syndecan-4 Are Involved in Membrane Fixation of LL-37 and Its Pro-Migratory Effect in Breast Cancer Cells

Chahrazed Habes et al.

BIOMOLECULES (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Exploring the Molecular Crosstalk between Pancreatic Bud and Mesenchyme in Embryogenesis: Novel Signals Involved

Ilaria Guerriero et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Oncology

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy

Thomas M. Ashton et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromso Study

Marit D. Solbu et al.

ATHEROSCLEROSIS (2018)

Add to Collection

Review Gastroenterology & Hepatology

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

Andrew McGuigan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer

Jun Yao et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Add to Collection

Article

Pancreatic Cancer: Pathogenesis and Diagnosis

Vedat Goral

Asian Pacific Journal of Cancer Prevention (2015)

Add to Collection

Review Oncology

Approach to Patients With Pancreatic Cancer Without Detectable Metastases

Gregory M. Heestand et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Review Oncology

Precision medicine for metastatic breast cancer-limitations and solutions

Monica Arnedos et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

Add to Collection

Review Oncology

Precision medicine for cancer with next-generation functional diagnostics

Adam A. Friedman et al.

NATURE REVIEWS CANCER (2015)

Add to Collection

Article Oncology

Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma

Merve Erdem et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)

Add to Collection

Article Pathology

Syndecan-4 and fibronectin in osteosarcoma

Ki Yong Na et al.

PATHOLOGY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.